Compare TECH & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TECH | BIRK |
|---|---|---|
| Founded | 1976 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 8.8B |
| IPO Year | 1989 | 2023 |
| Metric | TECH | BIRK |
|---|---|---|
| Price | $65.12 | $41.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 13 |
| Target Price | ★ $70.46 | $64.69 |
| AVG Volume (30 Days) | 1.6M | ★ 3.0M |
| Earning Date | 02-04-2026 | 02-19-2026 |
| Dividend Yield | ★ 0.49% | N/A |
| EPS Growth | N/A | ★ 83.10 |
| EPS | 0.49 | ★ 2.19 |
| Revenue | $1,216,732,000.00 | ★ $2,460,904,611.00 |
| Revenue This Year | $2.33 | $14.52 |
| Revenue Next Year | $7.05 | $14.40 |
| P/E Ratio | $133.64 | ★ $19.13 |
| Revenue Growth | 3.85 | ★ 16.22 |
| 52 Week Low | $46.01 | $38.16 |
| 52 Week High | $79.28 | $62.66 |
| Indicator | TECH | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 68.64 | 46.60 |
| Support Level | $58.40 | $40.59 |
| Resistance Level | $66.48 | $43.07 |
| Average True Range (ATR) | 1.57 | 1.81 |
| MACD | 0.78 | -0.20 |
| Stochastic Oscillator | 86.10 | 21.26 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).